239 related articles for article (PubMed ID: 35280762)
1. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
Front Oncol; 2022; 12():830470. PubMed ID: 35280762
[TBL] [Abstract][Full Text] [Related]
2. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
[TBL] [Abstract][Full Text] [Related]
3. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
[TBL] [Abstract][Full Text] [Related]
4. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
[TBL] [Abstract][Full Text] [Related]
5. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
Front Oncol; 2021; 11():784289. PubMed ID: 35155190
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
7. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
8. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
Front Oncol; 2022; 12():946800. PubMed ID: 36081555
[TBL] [Abstract][Full Text] [Related]
9. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection versus radiotherapy for clinical stage IA lung cancer ≤1 cm in size: A population-based study.
Huang W; Deng HY; Wu XN; Xu K; Li P; Lin MY; Yuan C; Zhou Q
Asian J Surg; 2023 Jan; 46(1):385-393. PubMed ID: 35525696
[TBL] [Abstract][Full Text] [Related]
11. The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection.
Choi SY; Moon MH; Moon Y
Transl Cancer Res; 2020 Oct; 9(10):6431-6443. PubMed ID: 35117251
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
[TBL] [Abstract][Full Text] [Related]
13. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
[TBL] [Abstract][Full Text] [Related]
14. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
[TBL] [Abstract][Full Text] [Related]
15. Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion: Data From 1,055 Cases of Cancers ≤ 3 cm.
Liang RB; Li P; Li BT; Jin JT; Rusch VW; Jones DR; Wu YL; Liu Q; Yang J; Yang MZ; Li S; Long H; Fu JH; Zhang LJ; Lin P; Rong TH; Hou X; Lin SX; Yang HX
Chest; 2021 Aug; 160(2):754-764. PubMed ID: 33745993
[TBL] [Abstract][Full Text] [Related]
16. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
Front Oncol; 2020; 10():661. PubMed ID: 32500023
[No Abstract] [Full Text] [Related]
17. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
18. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
Moon Y; Lee KY; Park JK
World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
[TBL] [Abstract][Full Text] [Related]
19. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
